InspireMD Gains Registration Clearance of its CGuard™ Embolic Prevention System (EPS) in Brazil

Regulatory approval of CGuard EPS in Brazil reflects not only the ANVISA'S recognition of CGuards differentiating features versus conventional carotid stents, but also the need for safer treatments for carotid artery disease.